Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4339 results

Sort By:

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Study ID: NCT07001748
Start Date: 2025-08-19
End Date: 2030-05-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

148

Intervention / Treatment

Standard of Care Chemotherapy

Biospecimen Collection

Computed Tomography

Diagnostic Laparoscopy

Intraperitoneal Port Placement

Magnetic Resonance Imaging

Intraperitoneal Paclitaxel

Sponsor

ECOG-ACRIN Cancer Research Group

Source: clinicaltrials.gov

Share:
Add to list

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Study ID: NCT07049926
Start Date: 2025-08-04
End Date: 2031-10-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Belzutifan

Zantal

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI

Study ID: NCT05114057
Start Date: 2025-12-01
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1380

Intervention / Treatment

Renal Angina Index (RAI)

Sponsor

Children's Hospital Medical Center, Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

Enjoying Affordable and Tasty Food Together

Study ID: NCT07036757
Start Date: 2025-09-28
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Meal Kit and Nutrition Education

Sponsor

University of Massachusetts, Lowell

Source: clinicaltrials.gov

Share:
Add to list

MeDex: No Perioperative Dexamethasone in Brain Metastases

Study ID: NCT07044557
Start Date: 2025-10
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

Withholding perioperative Dexamethasone

Sponsor

University of Louisville

Source: clinicaltrials.gov

Share:
Add to list

Families Left Behind

Study ID: NCT06854757
Start Date: 2026-09-01
End Date: 2030-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

340

Intervention / Treatment

RIVER

Enhanced care as usual

Sponsor

RAND

Source: clinicaltrials.gov

Share:
Add to list

Alleviating Burden of Chronic Musculoskeletal Pain in the Emergency Department

Study ID: NCT06077526
Start Date: 2026-01-13
End Date: 2027-05-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

P.E.A.K. Rx

Usual Care

Sponsor

Bridgewater College

Source: clinicaltrials.gov

Share:
Add to list

Comparing Super Pulse Fiber Thulium Laser and Holmium Laser for Ureteral Stone Fragmentation During Ureteroscopy

Study ID: NCT06667557
Start Date: 2025-11-20
End Date: 2028-10-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

136

Intervention / Treatment

Superpulse Thulium Fiber Laser (sTFL) Treatment

Holmium:YAG Laser (Ho:YAG) Treatment

Sponsor

Y is good

Source: clinicaltrials.gov

Share:
Add to list

Non-invasive Blood Pressure Monitoring in Carotid Surgery

Study ID: NCT06965257
Start Date: 2026-05
End Date: 2026-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Continuous non-invasive blood pressure monitoring

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Study ID: NCT06667726
Start Date: 2025-09-08
End Date: 2029-10-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

47

Intervention / Treatment

Computed Tomography

Fluorodopa F 18

Positron Emission Tomography

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list